Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Oral Bifidobacterium Longum CCFM1029 on Atopic Dermatitis in Infant

NCT05286047 is registered in ClinicalTrials.gov with Glac Biotech Co., Ltd as lead sponsor.

NCT NCT05286047
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05286047 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Oral Bifidobacterium Longum CCFM1029 on Atopic Dermatitis in Infant
Lead sponsor
Glac Biotech Co., Ltd
Phase
Not applicable
Overall status
Completed
Start date
September 23, 2022
Completion date
May 28, 2025
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis